Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Other Non-Current Liabilities (2023 - 2025)

Bio Essence has reported Other Non-Current Liabilities over the past 3 years, most recently at $301959.0 for Q1 2025.

  • Quarterly results put Other Non-Current Liabilities at $301959.0 for Q1 2025, up 438.32% from a year ago — trailing twelve months through Mar 2025 was $301959.0 (up 438.32% YoY), and the annual figure for FY2024 was $447414.0, down 54.88%.
  • Other Non-Current Liabilities for Q1 2025 was $301959.0 at Bio Essence, down from $447414.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for BIOE hit a ceiling of $991529.0 in Q4 2023 and a floor of $56093.0 in Q1 2024.
  • Median Other Non-Current Liabilities over the past 3 years was $447414.0 (2024), compared with a mean of $477505.4.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 54.88% in 2024 and later skyrocketed 438.32% in 2025.
  • Bio Essence's Other Non-Current Liabilities stood at $991529.0 in 2023, then crashed by 54.88% to $447414.0 in 2024, then tumbled by 32.51% to $301959.0 in 2025.
  • The last three reported values for Other Non-Current Liabilities were $301959.0 (Q1 2025), $447414.0 (Q4 2024), and $590532.0 (Q3 2024) per Business Quant data.